Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia

BACKGROUND. Older patients (≥60 years) with acute myeloid leukemia (AML) face difficult decisions regarding treatment with “intensive” chemotherapy that carries significant toxicity for a small chance of a cure versus “nonintensive” chemotherapy to control the disease, but with fewer side effects. H...

Descripción completa

Detalles Bibliográficos
Autores principales: El‐Jawahri, Areej, Nelson‐Lowe, Margaret, VanDusen, Harry, Traeger, Lara, Abel, Gregory A., Greer, Joseph A., Fathi, Amir, Steensma, David P., LeBlanc, Thomas W., Li, Zhigang, DeAngelo, Daniel, Wadleigh, Martha, Hobbs, Gabriela, Foster, Julia, Brunner, Andrew, Amrein, Philip, Stone, Richard M., Temel, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369944/
https://www.ncbi.nlm.nih.gov/pubmed/30139841
http://dx.doi.org/10.1634/theoncologist.2018-0317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369944/
https://www.ncbi.nlm.nih.gov/pubmed/30139841
http://dx.doi.org/10.1634/theoncologist.2018-0317

Ejemplares similares